References
- Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–820.10.1007/s00401-016-1545-110.1371/journal.pone.008326110.1038/onc.2013.51810.1007/s13277-016-4850-310.3109/1354750X.2010.52566410.1158/1078-0432.CCR-07-060910.1002/(ISSN)1097-014210.1038/nrc265710.1080/09674845.2004.1173265210.3109/1354750X.2014.996607
- Qi ZY, Shao C, Huang YL, et al. Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis. PLoS One. 2013;8(12):e83261.
- Kreis NN, Sanhaji M, Rieger MA, et al. p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells. Oncogene. 2014;33:5716–5728.
- Chedid M, Michieli P, Lengel C, et al. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene. 1994;9:3021–3024.
- Law JC, Deka A. Identification of a PstI polymorphism in the p21Cip1/Waf1 cyclin-dependent kinase inhibitor gene. Hum Genet. 1995;95(4):459–460.
- Sivoňová MK, Vilčková M, Kliment J, et al. Association of p53 and p21 polymorphisms with prostate cancer. Biomed Rep. 2015;3:707–714.
- Vargas-Torres SL, Portari EA, Silva AL, et al. Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the development of cervical neoplasia. Tumour Biol. 2016;37:10469–10478.
- Tornesello ML, Buonaguro L, Cristillo M, et al. MDM2 and CDKN1A gene polymorphisms and risk of Kaposi’s sarcoma in African and Caucasian patients. Biomarkers. 2011;16:42–50.
- Hirata H, Hinoda Y, Kikuno N, et al. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clin Cancer Res. 2007;13:4123–4129.
- Facher EA, Becich MJ, Deka A, et al. Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene. Cancer. 1997;79:2424–2429.
- Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400–414.
- Alenzi FQB. Links between apoptosis, proliferation and the cell cycle. Br J Biomed Sci. 2004;61:99–102.
- Chedid M, Michieli P, Lengel C, et al. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene. 1994;9:3021–3024.
- Shao A, Zheng L, Chen S, et al. p21, p53, TP53BP1 and p73 polymorphisms and the risk of gastric cardia adenocarcinoma in a Chinese population. Biomarkers. 2015;20:109–115.
- Gomes CC, Drummond SN, Guimarães AL, et al. P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med. 2008;37:151–156.